Jeffrey Wolf Selected Research

Jeffrey Wolf Research Topics

18	Multiple Myeloma 01/2023 - 06/2005
3	Neoplasms (Cancer) 03/2020 - 10/2008
2	Infections 01/2023 - 12/2022
2	Neutropenia 12/2022 - 12/2004
2	Squamous Cell Carcinoma of Head and Neck 12/2012 - 01/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2012 - 12/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2012 - 10/2011
1	Cytokine Release Syndrome 01/2023
1	cell-associated neurotoxicity 01/2023
1	Delirium 01/2023
1	Cytopenia 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Amyloidosis 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023
1	Bone Marrow Diseases (Bone Marrow Disease) 01/2023
1	Injection Site Reaction 12/2022
1	Hypersensitivity (Allergy) 12/2022
1	Lymphopenia (Lymphocytopenia) 12/2022
1	Macrophage Activation Syndrome 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2020
1	Cardiotoxicity 12/2020
1	Residual Neoplasm 01/2020
1	Hyperplasia 10/2019
1	Carcinogenesis 10/2019
1	Intestinal Neoplasms (Intestinal Cancer) 10/2019
1	Pneumonia (Pneumonitis) 01/2017
1	Epistaxis (Nosebleed) 11/2015
1	Melanoma (Melanoma, Malignant) 12/2012
1	Carcinoma (Carcinomatosis) 12/2012
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 04/2012
1	Polyneuropathies (Polyneuropathy) 09/2009
1	Feminization 04/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2008
1	Leukopenia 12/2004
1	Mucositis 12/2004
1	Deglutition Disorders (Dysphagia) 12/2004
1	Dehydration (Water Stress) 12/2004
1	Dermatitis 12/2004
1	Xerostomia 12/2004

5	Bortezomib (Velcade)FDA Link 01/2023 - 06/2005
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 06/2005
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 01/2021
4	Lenalidomide (CC 5013)FDA Link 01/2020 - 09/2009
3	B-Cell Maturation AntigenIBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 01/2017
2	daratumumabIBA 01/2023 - 12/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2012 - 02/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2012 - 12/2004
2	Carboplatin (JM8)FDA LinkGeneric 04/2012 - 12/2004
1	Immunoglobulin G (IgG)IBA 01/2023
1	lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA 12/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 03/2020
1	venetoclaxIBA 01/2020
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2019
1	CaptanIBA 10/2019
1	folpet (Phaltan)IBA 10/2019
1	chromium hexavalent ionIBA 10/2019
1	CarcinogensIBA 10/2019
1	Hypoxia-Inducible Factor 1IBA 10/2019
1	lorvotuzumab mertansineIBA 01/2019
1	isatuximabIBA 01/2017
1	Peptides (Polypeptides)IBA 12/2012
1	Hepatitis B e AntigensIBA 12/2012
1	VaccinesIBA 12/2012
1	FurinIBA 12/2012
1	Cetuximab (Erbitux)FDA Link 04/2012
1	AS 35IBA 04/2012
1	Drug CombinationsIBA 02/2010
1	Thalidomide (Thalomid)FDA Link 02/2010
1	Estrogens (Estrogen)FDA Link 04/2009
1	EnzymesIBA 04/2009
1	AtrazineIBA 04/2009
1	Aromatase (CYP19)IBA 04/2009
1	Amifostine (Ethyol)FDA LinkGeneric 12/2004

13	Therapeutics 01/2023 - 12/2004
3	Drug Therapy (Chemotherapy) 03/2022 - 12/2004
3	Radiotherapy 04/2012 - 12/2004
2	Chemoradiotherapy 04/2012 - 01/2010
1	Hematopoietic Stem Cell Transplantation 01/2023
1	Stem Cell Transplantation 03/2022
1	Extracorporeal Membrane Oxygenation 11/2015
1	Gastrostomy 10/2011
1	Neck Dissection (Radical Neck Dissection) 01/2010
1	Drug Tapering 10/2008
1	Retreatment 10/2008